{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:04:34Z","timestamp":1785492274908,"version":"3.56.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background and aims<\/jats:title><jats:p>Cardiac structural and functional changes have been demonstrated in patients with non-alcoholic fatty liver disease (NAFLD). Because of the frequent association of NAFLD with hypertension, we aimed to examine the relationship of liver steatosis with left ventricular (LV) changes in patients with hypertension.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>In a cross-sectional study, we included 360 untreated, essential hypertensive patients who were free of major cardiovascular and renal complications. Liver steatosis was assessed by three different biochemical scores (NAFLD Liver Fat Score, LFS; Fatty Liver Index, FLI; Hepatic Steatosis Index, HSI). Echocardiography was performed with standard B-mode and tissue-Doppler imaging.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>LV hypertrophy was present in 19.4% and LV diastolic dysfunction in 49.2% of patients who had significantly higher body mass index (BMI), blood pressure (BP), and homeostatic model assessment (HOMA) index and higher frequency of the metabolic syndrome and liver steatosis that was defined by presence of 2 or more positive scores. LV mass index increased progressively across patients who had none, 1, or 2 or more liver steatosis scores, with associated progressive worsening of LV diastolic function. LV mass index was significantly and positively correlated with age, BMI, BP, HOMA-index, LFS, and HSI. Logistic regression analysis showed that age, BP, and liver steatosis scores independently predicted LV hypertrophy and diastolic dysfunction. Liver steatosis independently predicted LV dysfunction but not LV hypertrophy even after inclusion in analysis of the HOMA-index.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>NAFLD is associated with LV hypertrophy and diastolic dysfunction in untreated patients with hypertension. In hypertension, NAFLD could contribute to LV diastolic dysfunction with mechanisms unrelated to insulin resistance.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.1030968","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T04:37:41Z","timestamp":1665635861000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Association of non-alcoholic fatty liver disease with left ventricular changes in treatment-naive patients with uncomplicated hypertension"],"prefix":"10.3389","volume":"9","author":[{"given":"Cristiana","family":"Catena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Brosolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Da Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Donnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Bulfone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Soardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo A.","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases.","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-020-00570-y","article-title":"NAFLD as a continuum: from obesity to metabolic syndrome and diabetes.","volume":"12","author":"Godoy-Matos","year":"2020","journal-title":"Diabetol Metab Syndr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jacc.2018.11.050","article-title":"Nonalcoholic fatty liver disease and the heart: JACC state of the art review.","volume":"73","author":"Stahl","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.atherosclerosis.2017.11.012","article-title":"Subclinical cerebrovascular disease in NAFLD without overt risk factors for atherosclerosis.","volume":"268","author":"Airaghi","year":"2018","journal-title":"Atherosclerosis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-2001-12925","article-title":"Nonalcoholic steatohepatitis: definition and pathology.","volume":"21","author":"Brunt","year":"2001","journal-title":"Semin Liver Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1111\/apt.12963","article-title":"Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease.","volume":"40","author":"Fedchuck","year":"2014","journal-title":"Aliment Pharmacol Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.jhep.2021.05.008","article-title":"Long-term outcomes and predictive ability of noninvasive scoring systems in patients with nonalcoholic fatty liver disease.","volume":"75","author":"Younes","year":"2021","journal-title":"J Hepatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/HJH.0000000000002750","article-title":"Nonalcoholic fatty liver disease and left ventricular remodelling: now the prospective evidence.","volume":"39","author":"Sechi","year":"2021","journal-title":"J Hypertens."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014279","article-title":"Longitudinal association of non-alcoholic fatty liver disease with changes in myocardial structure and function: the CARDIA study.","volume":"9","author":"VanWagner","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B10","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1097\/HJH.0000000000002716","article-title":"Fatty liver index and left ventricular mass: prospective associations from two independent cohorts.","volume":"39","author":"Li","year":"2020","journal-title":"J Hypertens."},{"key":"B11","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jhep.2012.11.015","article-title":"Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease.","volume":"58","author":"Hallsworth","year":"2013","journal-title":"J Hepatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.jhep.2014.11.030","article-title":"Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease.","volume":"62","author":"Petta","year":"2015","journal-title":"J Hepatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ijcard.2016.06.180","article-title":"Echocardiography and NAFLD (non-alcoholic fatty liver disease).","volume":"221","author":"Trovato","year":"2016","journal-title":"Int J Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jhep.2017.11.023","article-title":"Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.","volume":"68","author":"Lee","year":"2018","journal-title":"J Hepatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s12020-019-02070-0","article-title":"Association between nonalcoholic fatty liver disease and cardiac function and structure-a meta-analysis.","volume":"66","author":"Borges-Canha","year":"2019","journal-title":"Endocrine."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.dld.2018.09.004","article-title":"Association between diastolic cardiac dysfunction and nonalcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"50","author":"Wijarnpreecha","year":"2018","journal-title":"Dig Liver Dis."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.021430","article-title":"Elevated fatty liver index is independently associated with new onset of hypertension during a 10-year period in both male and female subjects.","volume":"10","author":"Higashiura","year":"2021","journal-title":"J Am Heart Assoc."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8463640","article-title":"Bidirectional association between hypertension and NAFLD: a systematic review and meta-analysis of observational studies.","volume":"2022","author":"Li","year":"2022","journal-title":"Int J Endocrinol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0195-668X(02)00428-1","article-title":"Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample.","volume":"24","author":"Fischer","year":"2003","journal-title":"Eur Heart J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1161\/CIRCULATIONAHA.108.793471","article-title":"Cardiac dysfunction assessed by echocardiographic tissue Doppler imaging is an independent predictor of mortality in the general population.","volume":"119","author":"Mogelvang","year":"2009","journal-title":"Circulation."},{"key":"B21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1161\/01.HYP.38.1.13","article-title":"Link of nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy.","volume":"38","author":"de Simone","year":"2001","journal-title":"Hypertension."},{"key":"B22","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.cjca.2011.02.008","article-title":"Diastolic heart failure: progress, treatment challenges and prevention.","volume":"27","author":"Wood","year":"2011","journal-title":"Can J Cardiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1046\/j.1523-1755.1999.00621.x","article-title":"Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.","volume":"56","author":"Sechi","year":"1999","journal-title":"Kidney Int."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension.","volume":"36","author":"Williams","year":"2018","journal-title":"J Hypertens."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1161\/HYPERTENSIONAHA.116.08145","article-title":"Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients.","volume":"68","author":"Catena","year":"2016","journal-title":"Hypertension."},{"key":"B26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00004872-200302000-00018","article-title":"Serum lipoprotein(a) and alcohol consumption in hypertension: possible relevance for cardiovascular damage.","volume":"21","author":"Catena","year":"2003","journal-title":"J Hypertens."},{"key":"B27","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.2337\/dc22-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes 2022.","year":"2022","journal-title":"Diabetes Care."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific Statement.","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1161\/HYPERTENSIONAHA.115.05285","article-title":"Plasma aldosterone and left ventricular diastolic function in treatment-na\u00efve patients with hypertension; tissue-Doppler imaging study.","volume":"65","author":"Catena","year":"2015","journal-title":"Hypertension."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/HYPERTENSIONAHA.122.19472","article-title":"Differences in regulation of cortisol secretion contribute to left ventricular abnormalities in patients with essential hypertension.","volume":"79","author":"Brosolo","year":"2022","journal-title":"Hypertension."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and Chamber Quantification Writing Group, developed in conjunction with the European Society of Cardiology.","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr."},{"key":"B32","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"B33","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/hep.27869","article-title":"Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study.","volume":"62","author":"VanWagner","year":"2015","journal-title":"Hepatology."},{"key":"B34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/BF03345421","article-title":"Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive type 2 diabetic individuals.","volume":"35","author":"Mantovani","year":"2012","journal-title":"J Endocrinol Invest."},{"key":"B35","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.numecd.2008.12.007","article-title":"Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension.","volume":"19","author":"Fallo","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/hep.22429","article-title":"Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.","volume":"48","author":"Fracanzani","year":"2008","journal-title":"Hepatology."},{"key":"B37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1089\/met.2010.0140","article-title":"Oxidative stress is activated by free fatty acids in cultured human hepatocytes.","volume":"9","author":"Soardo","year":"2011","journal-title":"Metab Syndr Relat Disord."},{"key":"B38","doi-asserted-by":"publisher","first-page":"H1597","DOI":"10.1152\/ajpheart.00026.2004","article-title":"Insulin resistance and hypertension.","volume":"286","author":"Sowers","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.008315","article-title":"Relation of insulin resistance to longitudinal changes in left ventricular structure and function in a general population.","volume":"7","author":"Cauwenberghs","year":"2018","journal-title":"J Am Heart Assoc."},{"key":"B40","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/hep.30429","article-title":"Modulation of insulin resistance in nonalcoholic fatty liver disease.","volume":"70","author":"Khan","year":"2019","journal-title":"Hepatology."},{"key":"B41","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1161\/01.HYP.27.4.955","article-title":"Abnormalities of insulin receptors in spontaneously hypertensive rats.","volume":"27","author":"Sechi","year":"1996","journal-title":"Hypertension."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17050675","article-title":"Vascular damage in patients with nonalcoholic fatty liver disease: possible role of iron and ferritin.","volume":"17","author":"Pisano","year":"2016","journal-title":"Int J Mol Sci."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10020249","article-title":"Hypercoagulability in patients with non-alcoholic fatty liver disease (NAFLD): causes and consequences.","volume":"20","author":"Tripodi","year":"2022","journal-title":"Biomedicines."},{"key":"B44","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1161\/01.HYP.36.6.978","article-title":"Relationship of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension.","volume":"36","author":"Sechi","year":"2000","journal-title":"Hypertension."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1030968\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T04:37:46Z","timestamp":1665635866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1030968\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,13]]},"references-count":44,"alternative-id":["10.3389\/fcvm.2022.1030968"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.1030968","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,13]]},"article-number":"1030968"}}